重庆秦安机电股份有限公司董事会 关于公司发行股份及支付现金购买资产 并募集配套资金暨关联交易履行法定程序完备性、 合规性及提交法律文件有效性的说明 重庆秦安机电股份有限公司（以下简称"公司"）拟以发行股份及支付现金 的方式购买安徽亦高光电科技有限责任公司99%股权，并募集配套资金（以下简 称"本次交易"）。根据《中华人民共和国公司法》《中华人民共和国证券法》 《上海证券交易所股票上市规则》《上市公司重大资产重组管理办法》《公开发 行证券的公司信息披露内容与格式准则第26号——上市公司重大资产重组》等法 律法规和规范性文件的规定，公司董事会就本次交易履行法定程序的完备性、合 规性及提交法律文件的有效性进行如下说明： 一、关于本次交易履行法定程序完备性、合规性的说明 （一）公司与交易对方就本次交易事宜进行初步磋商时，立即采取了必要且 充分的保密措施，限定相关内幕信息的知悉范围。 （二）公司根据交易进程情况制作了重大事项进程备忘录并经相关人员签字 确认。公司对本次交易涉及的内幕信息知情人进行了登记，并将有关材料向上海 证券交易所进行了上报。 （五）2025年7月10日，公司召开公司第五届董事会第一次独立董事专门会 ...

证券代码：603758 证券简称：秦安股份 上市地点：上海证券交易所 重庆秦安机电股份有限公司 发行股份及支付现金购买资产 并募集配套资金暨关联交易预案 | 交易对方类型 | 交易对方名称 | | --- | --- | | 发行股份及支付 | 饶亦然、深圳市亦高实业有限公司、深圳市远致星火私募股 | | | 权投资基金合伙企业（有限合伙）、西藏华建兴业实业有限 | | | 公司、珠海亦高投资合伙企业（有限合伙）、深圳市吉城光 | | 现金购买资产 | 电科技有限公司、新余市长业亿立创业投资合伙企业（有限 | | | 合伙）、深圳市君汇鑫亦咨询合伙企业（有限合伙）、厦门 | | | 市穗满时时投资合伙企业（有限合伙）、深圳市清显科技有 | | | 限公司、李俊华、尤俊衡 | | 募集配套资金 | 不超过 名符合条件的特定投资者 35 | 二〇二五年七月 重庆秦安机电股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易预案 上市公司声明 本公司及全体董事、监事、高级管理人员保证本预案及其摘要内容的真实、 准确、完整，对本预案及其摘要的虚假记载、误导性陈述或者重大遗漏负相应 的法律责任。 本公司控股股东 ...

证券代码：603758 证券简称：秦安股份 公告编号：2025-022 重庆秦安机电股份有限公司 关于披露发行股份及支付现金购买资产并募集配套资金暨关 联交易预案暨公司股票复牌的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因筹划发行股份及支付现金购买资产并募集配套资金暨关联交易事项,本公 司的相关证券停复牌情况如下： | 证券代码 | 证券简称 | 停复牌类型 | | 停牌起始日 | 停牌 期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603758 | 秦安股份 | A 股 | 复牌 | | | 2025/7/10 | 2025/7/11 | 一、停牌情况和工作安排 重庆秦安机电股份有限公司（以下简称"公司"）正在筹划以发行股份及支 付现金的方式购买安徽亦高光电科技有限责任公司99%股份，并同时募集配套资金 （以下简称"本次交易"）。 重庆秦安机电股份有限公司董事会 因本次交易尚 ...

证券代码：603758 证券简称：秦安股份 上市地点：上海证券交易所 重庆秦安机电股份有限公司 发行股份及支付现金购买资产 并募集配套资金暨关联交易预案（摘要） | 交易对方类型 | 交易对方名称 | | --- | --- | | 发行股份及支付 | 饶亦然、深圳市亦高实业有限公司、深圳市远致星火私募股 | | | 权投资基金合伙企业（有限合伙）、西藏华建兴业实业有限 | | | 公司、珠海亦高投资合伙企业（有限合伙）、深圳市吉城光 | | 现金购买资产 | 电科技有限公司、新余市长业亿立创业投资合伙企业（有限 | | | 合伙）、深圳市君汇鑫亦咨询合伙企业（有限合伙）、厦门 | | | 市穗满时时投资合伙企业（有限合伙）、深圳市清显科技有 | | | 限公司、李俊华、尤俊衡 | | 募集配套资金 | 不超过 名符合条件的特定投资者 35 | 二〇二五年七月 重庆秦安机电股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易预案（摘要） 负责；因本次交易引致的投资风险，由投资者自行负责。投资者在评价本公司 本次交易时，除重组预案及摘要的内容和与重组预案及其摘要同时披露的相关 文件外，还应特别认真地考 ...

秦安股份（603758）公告，公司计划通过发行股份及支付现金方式购买安徽亦高光电科技有限责任公司 99%股权，并募集配套资金。本次交易的交易对方包括饶亦然、深圳市亦高实业有限公司等12名交易对 方。截至本预案摘要签署日，标的公司的审计和评估工作尚未完成，本次交易的具体交易价格尚未确 定。标的资产的交易价格将以符合法律规定的评估机构出具的资产评估报告确定的评估结果为基础，由 交易各方协商确定，并在重组报告书中予以披露。 ...

Summary of Key Points Core Insights - The report highlights the listing and trading activities of various ETFs and bonds on July 10, 2025, indicating a busy market day with multiple announcements regarding suspensions and resumption of trading for various financial instruments [1][2][3][4][5][6][7][8][9]. Group 1: Listings and Trading Activities - The report mentions the listing of 127110 Guanghe Convertible Bond and 301603 Qiaofeng Intelligent on July 10, 2025, marking significant events for these financial instruments [1]. - Several ETFs, including 159209 China Merchants CSI All-Share Dividend Quality ETF and 159232 Southern CSI All-Share Free Cash Flow ETF, announced dividend distributions and were temporarily suspended from trading during specific hours on the same day [1]. - The report notes that multiple ETFs, such as 159351 Jiashi CSI A500 ETF and 159355 Huabao CSI 800 Dividend Low Volatility ETF, also experienced similar trading suspensions due to dividend announcements [1]. Group 2: Special Suspensions - The report details the special suspension of stock 000545 Jinpu Titanium Industry due to significant asset restructuring and related transactions, effective from July 1, 2025 [2]. - Other financial instruments, including various SCPs from Zhonglin Group, have been suspended since November 21, 2023, indicating ongoing issues or restructuring within those entities [2][3][4][5][6][7][8][9]. Group 3: General Market Activity - The report reflects a general trend of increased market activity with multiple announcements of trading suspensions and resumption, indicating a dynamic environment for investors [1][2][3][4][5][6][7][8][9]. - The focus on dividend announcements and asset restructuring suggests a strategic shift among companies to enhance shareholder value and manage financial health [1][2][3][4][5][6][7][8][9].

Group 1 - Notable fund manager Wan Minyuan increased holdings in Dongfang Biological, holding 5 million shares, representing 2.48% of the company, ranking as the fifth largest shareholder [3] - Dongfang Biological has been consistently favored by Wan Minyuan's fund since Q2 2024, with an increase of 778,300 shares compared to Q1 2024 [3] - Dongfang Biological specializes in the research, production, and sales of in vitro diagnostic products and has over 50 subsidiaries globally [3] Group 2 - Fund managers Yan Siqian and Lü Yuechao reduced their stakes in Qin'an Co., with new entries in the top ten shareholders, including Liu Xiaofei's fund [6] - Qin'an Co. has seen its stock price double this year, with a significant acquisition of 99% of Anhui Yigao Optoelectronics [6] - The company specializes in manufacturing core components for automotive engine power systems and has major clients including Changan Ford and Geely [6] Group 3 - Fund manager Xu Yan reduced holdings in Wufangzhai, with a current holding of 1.25 million shares, down from 2.22 million shares previously [8] - Wufangzhai, founded in 1921, focuses on glutinous rice food products and has been diversifying into mooncakes and other food items [9] - The company faced a public relations crisis earlier this year, impacting consumer trust and leading to a decline in stock price [9]

Core Viewpoint - The article reveals the latest stock adjustments made by several well-known fund managers, highlighting their investment strategies and the performance of specific companies in the market [1]. Group 1: Investment Movements - Wan Minyuan increased his stake in Oriental Bio, holding 5 million shares, representing 2.48% of the company, making him the fifth-largest shareholder. This reflects a significant increase from 4.22 million shares (2.09%) in the first quarter, indicating a 77,830-share increase in the second quarter [3]. - Fund managers Yan Siqian and Lü Yuechao reduced their holdings in Qin'an Co., with notable new entries from Liu Xiaofei's fund, which holds 1.68 million shares, ranking as the ninth-largest shareholder. The three funds that reduced their stakes were previously among the top shareholders [5][6]. - Xu Yan decreased his holdings in Wufangzhai, with his fund holding 1.25 million shares (0.63%), down from 2.22 million shares (1.12%) earlier this year. This reduction follows a trend of significant divestment since the fourth quarter of the previous year [8][9]. Group 2: Company Performance - Oriental Bio specializes in the research, production, and sales of in vitro diagnostic products and has established over 50 subsidiaries globally, employing a professional team of over 3,000 [3]. - Qin'an Co. is a manufacturer of core components for automotive engine power systems and has seen its stock price double this year, with a recent acquisition of a 99% stake in Anhui Yigao Optoelectronics [5][6]. - Wufangzhai, founded in 1921, focuses on glutinous rice food products and has been diversifying its offerings, including mooncakes and egg products, to seek new growth avenues [8].

证券代码：603758 证券简称：秦安股份 公告编号：2025-019 根据《上海证券交易所上市公司自律监管指引第4号——停复牌》相关规定， 现将公司股票停牌前1个交易日（即2025年6月27日）的前十大股东和前十大流通 股股东的名称、持股数量和所持股份类别等情况披露如下。 截至2025年6月27日，公司股本总数为438,797,049股，均为无限售条件流通 股，公司前十大股东及前十大流通股股东数据一致，其持股情况如下： | | 持股数量 占总股本比例 | | | --- | --- | --- | | 序号 | （股） （%） | 股东名称 | | | 年员工 | 重庆秦安机电股份有限公司－2023 | | | 持股计划 持股数量 占总股本比例 | | | 序号 | | 股东名称 | | | （股） （%） | | | | | 中国工商银行股份有限公司——诺安灵活 | | | | 配置混合型证券投资基金 | | | | 烟台招金私募投资基金管理有限公司—— | | | 招金 | FOF 1 精选 号私募证券投资基金 | 注：前十名股东中回购专户情况说明：重庆秦安机电股份有限公司回购专用证券账户持有 特此公告 ...

Core Viewpoint - The company is planning to acquire 99% of Anhui Yigao Optoelectronics Technology Co., Ltd. through a combination of issuing shares and cash payment, while also raising supporting funds, which constitutes a related party transaction [1][2][3] Group 1: Transaction Details - The transaction is expected not to meet the criteria for a major asset restructuring as defined by the relevant regulations [1] - The transaction will not result in a change of the company's actual controller and does not constitute a restructuring listing [1] - The company is currently in the planning stage of the transaction, with no formal agreements signed yet [3] Group 2: Stock Suspension - The company's stock has been suspended since June 30, 2025, to ensure fair information disclosure and protect investor interests, with an expected suspension period of no more than 10 trading days [2] - During the suspension, the company will continue to communicate updates regarding the transaction and will disclose information as necessary [2][3] Group 3: Regulatory Approval - The transaction requires approval from the company's board of directors, shareholders, and relevant regulatory authorities before it can be officially implemented [3]